The relationship between gastrointestinal complaints and the use of pancreatin-derivated medications after cholecystectomy

Sefa Ergün; Betul Guzelyuz; Batuhan Tozakoglu

Makale detayları

The relationship between gastrointestinal complaints and the use of pancreatin-derivated medications after cholecystectomy

Yazarlar:

Sefa Ergün | Betul Guzelyuz | Batuhan Tozakoglu

Yayıncı:

Marmara University

Ana Başlıklar:

Surgery (Other)

Dergi:

Marmara Medical Journal Vol.37 Issue 2, pp.208-213

Belge Tipi:

Makale

Yayın Tarihi:

5/2024

Belge Dili:

İngilizce

Document ID (Org No.):

2001317364

pISSN:

1019-1941

Anahtar kelimeler:

Özet:

 Objective: The aim of this study was to investigate the relationship between pancreatin-derived medications and the treatability of gastrointestinal complaints after cholecystectomy. Patients and Methods: The relationship between postoperative symptomatic status and the use of proton pump inhibitors PPIs and pancreatin-derivated medications in patients admitted to our hepatobiliary surgery service who underwent cholecystectomy was retrospectively analyzed. IBM SPSS Statistics 23 IBM SPSS,Turkey was used for statistical analysis. Descriptive statistical methods mean, standard deviation, median, frequency, ratio, minimum, maximum were used to evaluate the study data. Pearson Chi-Square Test and Fishers Exact test were used to compare qualitative data. Significance was evaluated at the p0.05 level. Results: Proton pump inhibitors and pancreatin-derivatives were prescribed to all patients in the postoperative period. Although, the rate of postoperative asymptomatic course was higher in all patients, the rate of postoperative symptoms was found to be higher in patients who received PPI and pancreatin therapy p0.001, p0.022; p0.01. Conclusions: Although, the high rate of asymptomatic postoperative course in all patients indicates that cholecystectomy alone is curative, some symptoms may persist in the postoperative period and it was found to be more frequent in patients who used PPI and pancreatin-derived medications in the postoperative period.

 Objective: The aim of this study was to investigate the relationship between pancreatin-derived medications and the treatability of gastrointestinal complaints after cholecystectomy. Patients and Methods: The relationship between postoperative symptomatic status and the use of proton pump inhibitors PPIs and pancreatin-derivated medications in patients admitted to our hepatobiliary surgery service who underwent cholecystectomy was retrospectively analyzed. IBM SPSS Statistics 23 IBM SPSS,Turkey was used for statistical analysis. Descriptive statistical methods mean, standard deviation, median, frequency, ratio, minimum, maximum were used to evaluate the study data. Pearson Chi-Square Test and Fishers Exact test were used to compare qualitative data. Significance was evaluated at the p0.05 level. Results: Proton pump inhibitors and pancreatin-derivatives were prescribed to all patients in the postoperative period. Although, the rate of postoperative asymptomatic course was higher in all patients, the rate of postoperative symptoms was found to be higher in patients who received PPI and pancreatin therapy p0.001, p0.022; p0.01. Conclusions: Although, the high rate of asymptomatic postoperative course in all patients indicates that cholecystectomy alone is curative, some symptoms may persist in the postoperative period and it was found to be more frequent in patients who used PPI and pancreatin-derived medications in the postoperative period.

 Objective: The aim of this study was to investigate the relationship between pancreatin-derived medications and the treatability of gastrointestinal complaints after cholecystectomy. Patients and Methods: The relationship between postoperative symptomatic status and the use of proton pump inhibitors PPIs and pancreatin-derivated medications in patients admitted to our hepatobiliary surgery service who underwent cholecystectomy was retrospectively analyzed. IBM SPSS Statistics 23 IBM SPSS,Turkey was used for statistical analysis. Descriptive statistical methods mean, standard deviation, median, frequency, ratio, minimum, maximum were used to evaluate the study data. Pearson Chi-Square Test and Fishers Exact test were used to compare qualitative data. Significance was evaluated at the p0.05 level. Results: Proton pump inhibitors and pancreatin-derivatives were prescribed to all patients in the postoperative period. Although, the rate of postoperative asymptomatic course was higher in all patients, the rate of postoperative symptoms was found to be higher in patients who received PPI and pancreatin therapy p0.001, p0.022; p0.01. Conclusions: Although, the high rate of asymptomatic postoperative course in all patients indicates that cholecystectomy alone is curative, some symptoms may persist in the postoperative period and it was found to be more frequent in patients who used PPI and pancreatin-derived medications in the postoperative period.

 Objective: The aim of this study was to investigate the relationship between pancreatin-derived medications and the treatability of gastrointestinal complaints after cholecystectomy. Patients and Methods: The relationship between postoperative symptomatic status and the use of proton pump inhibitors PPIs and pancreatin-derivated medications in patients admitted to our hepatobiliary surgery service who underwent cholecystectomy was retrospectively analyzed. IBM SPSS Statistics 23 IBM SPSS,Turkey was used for statistical analysis. Descriptive statistical methods mean, standard deviation, median, frequency, ratio, minimum, maximum were used to evaluate the study data. Pearson Chi-Square Test and Fishers Exact test were used to compare qualitative data. Significance was evaluated at the p0.05 level. Results: Proton pump inhibitors and pancreatin-derivatives were prescribed to all patients in the postoperative period. Although, the rate of postoperative asymptomatic course was higher in all patients, the rate of postoperative symptoms was found to be higher in patients who received PPI and pancreatin therapy p0.001, p0.022; p0.01. Conclusions: Although, the high rate of asymptomatic postoperative course in all patients indicates that cholecystectomy alone is curative, some symptoms may persist in the postoperative period and it was found to be more frequent in patients who used PPI and pancreatin-derived medications in the postoperative period.

Makale detayları

The relationship between gastrointestinal complaints and the use of pancreatin-derivated medications after cholecystectomy

Yazarlar:

Sefa Ergün | Betul Guzelyuz | Batuhan Tozakoglu

Yayıncı:

Marmara University

Ana Başlıklar:

Surgery (Other)

Dergi:

Marmara Medical Journal Vol.37 Issue 2, pp.208-213

Belge Tipi:

Makale

Yayın Tarihi:

5/2024

Belge Dili:

İngilizce

Document ID (Org No.):

2001317364

pISSN:

1019-1941

Cholecystectomy

Pancreatin-derivatives

Proton Pump Inhibitors

Dyspepsia

Sayı

Makale detayları

The relationship between gastrointestinal complaints and the use of pancreatin-derivated medications after cholecystectomy

Yazarlar: Sefa Ergün | Betul Guzelyuz | Batuhan Tozakoglu

Yayıncı: Marmara University

Ana Başlıklar: Surgery (Other)

Dergi: Marmara Medical Journal Vol.37 Issue 2, pp.208-213

Belge Tipi: Makale

Yayın Tarihi: 5/2024

Belge Dili: İngilizce

Document ID (Org No.): 2001317364

pISSN: 1019-1941

Cholecystectomy

Pancreatin-derivatives

Proton Pump Inhibitors

Dyspepsia

Sayı

Yazarlar:

Sefa Ergün | Betul Guzelyuz | Batuhan Tozakoglu

Yayıncı:

Marmara University

Ana Başlıklar:

Surgery (Other)

Dergi:

Marmara Medical Journal Vol.37 Issue 2, pp.208-213

Belge Tipi:

Makale

Yayın Tarihi:

5/2024

Belge Dili:

İngilizce

Document ID (Org No.):

2001317364

pISSN:

1019-1941